BoobyBiome

To add a bio or update company history, please click update information.

News from BoobyBiome

BoobyBiome secures £2.5m seed round led by Empirical Ventures to advance breast milk microbiome tech

8 Sept 2025

BoobyBiome secures £2.5m seed round led by Empirical Ventures to advance breast milk microbiome tech

BoobyBiome develops technology that preserves the microbiome of breast milk and supports infant gut health, including specialised storage solutions and live microbiome supplements.

BoobyBiome

Life Sciences
London, United Kingdom
£2.5m
boobybiome.com
Update Information

More venture news

Imperagen
21 May 2026
Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
SeedLife Sciences
Infex Therapeutic
12 May 2026
Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
EquityLife Sciences
Scarlet Therapeutics
11 May 2026
Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
SeedLife Sciences

BoobyBiome

News from BoobyBiome

BoobyBiome secures £2.5m seed round led by Empirical Ventures to advance breast milk microbiome tech

More venture news

Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering

Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments

Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases